Colorectal SSG March 2015 Research Wendy Cook, Research Delivery Manager Delivering clinical research to make patients, and the NHS, better dd/mm/yyyy
Cover • Overview of network changes • Overview of research activity r • Discussion re new studies for the portfolio 2
History • April 2013 • Cancer Network dissolved • SSG’s in the main stopped in Peninsula Network • Historically Peninsula Cancer Research Network • RD&E, N Devon, S Devon, Plymouth and RCHT • 1 of 32 Cancer networks • Peninsula, a very successful network • Governed by the NCRN (National cancer research Network) • April 2014 Research Transition
Transition • 15 Local Research Networks, Nationally. • I LRN has 30 specialties • Geographical changes • Area now includes Musgrove Park and Yeovil • New name • CRN: South West Peninsula (Local Research Network) • Local governance • 1 funding stream • Funding given to Trusts in 1 block, not broken down into cancer, diabetes, stroke etc 4
South West Peninsula CRN Hospital Size Yeovil District Hospital NHS Small Acute Foundation Trust Taunton and Somerset NHS Medium Foundation Trust Acute Northern Devon Healthcare NHS Small Acute Trust Royal Devon and Exeter NHS Large Acute Foundation Trust South Devon Healthcare NHS Medium Foundation Trust Acute Plymouth Hospitals NHS Trust Large Acute Royal Cornwall Hospitals NHS Trust Large Acute
Structure 6
Management of Division Performance Management and portfolio development • LPMS (EdGE) RAG review FPFV and T2T • Tracking of EOI return rates • Identification of new studies and promotion • Level 1 and level 2 studies, commercial and non commercial • Identify blocks and escalate e.g. ETC’s, supporting services • Coordinate regional team meetings/forums, workshops, share good practice , work collaboratively • Attend national cancer research meetings • Attend SSG’s • Providing recruitment data and trials information to the SSG • Support Peer Review 7
Recruitment Trust Study CSG 2013/2014 2014/2015 Total Plymouth Hospitals NHS Trust CReST Colorectal Cancer Group 2 5 Plymouth Hospitals NHS Trust Pulmonary Metastasectomy in Colorectal Cancer (PulMICC) Colorectal Cancer Group 6 3 14 Royal Cornwall Hospitals NHS Trust MARVEL Colorectal Cancer Group 9 9 Royal Cornwall Hospitals NHS Trust NSCCG Colorectal Cancer Group 1 244 Royal Devon and Exeter NHS Foundation Trust Aristotle Colorectal Cancer Group 3 4 Royal Devon and Exeter NHS Foundation Trust CORGI Colorectal Cancer Group 24 15 166 Royal Devon and Exeter NHS Foundation Trust Does aspirin increase the clinical response to chemo-radiotherapy? Colorectal Cancer Group 7 7 Royal Devon and Exeter NHS Foundation Trust NSCCG Colorectal Cancer Group 1 325 South Devon Healthcare NHS Foundation Trust ROLARR (RObotic versus LAparoscopic Resection for Rectal cancer) Colorectal Cancer Group 3 2 13 South Devon Healthcare NHS Foundation Trust The impact of robotic surgery on teamwork (v1) Colorectal Cancer Group 2 2 Taunton and Somerset NHS Foundation Trust FOCUS-4: Molecular selection of therapy in colorectal cancer Colorectal Cancer Group 1 1 Taunton and Somerset NHS Foundation Trust FOxTROT Colorectal Cancer Group 2 1 8 Taunton and Somerset NHS Foundation Trust NSCCG Colorectal Cancer Group 1 130 Taunton and Somerset NHS Foundation Trust STARRCAT Trial: Surgical Timing After Radiotherapy for Rectal Cancer Colorectal Cancer Group 3 1 4 Yeovil District Hospital NHS Foundation Trust Aristotle Colorectal Cancer Group 1 1 8
Historical recruitment Pre Trust 2008/09 2009/10 2010/11 2011/12 2012/013 2013/14 2014/15 Total 2008/2009 N Devon 178 24 15 31 23 10 3 284 Plym 563 8 35 30 27 43 7 5 718 RCHT 694 53 59 48 143 55 12 10 1074 RD&E 327 14 83 60 64 17 24 26 615 S Devon 195 7 19 23 38 19 9 4 314 Taunton 183 25 31 13 48 15 11 4 330 Yeovil 234 38 69 30 46 30 12 1 460 9
Focus 4 - Issues • Open for 12 months. 46/100 sites are open. • Not all Level 3 sites are open. This is a priority with the Trial Centre • Training on electronic data has been an issue, delaying set up at sites. • Capacity issues at the TC which are currently being addressed. • Sites are finding the CT schedule very tight, which leads to patients being excluded. 10
cont • Trial management team are looking at the platelet count inc/ex re evidence. There may be a possibility that this may be amended. • Changing site study Level - Site level was determined by the information sites submitted to the TC. If a site does not agree with their Level (of treatment) this can be discussed with the TC and levels can be changed but there needs to be dialogue between site and TC. 11
Division 1 • Duncan Wheatley, Clinical Specialty Lead duncan.wheatley@rcht.cornwall.nhs.uk 01872 258312 • Wendy Cook, Research Delivery Manager wcook1@nhs.net 01392 406995 • Ann Courtman, Administrator ann.courtman@nhs.net 01392 406966 • Subspecialty leads Nader Francis Nader.Francis@YDH.NHS.UK 12
An invite to Cancer Research Symposium From Clinical Trials to Clinical Practice Hosted by RD&E Jenny Forrest & Kate Scatchard, Consultant Clinical Oncologists at Gipsy Hill Hotel, Exeter Friday 15 th May 2015 Contact ann.courtman@nhs.net for more information on 01392 406996 13
Recommend
More recommend
